PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Mar-2023 Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Edgio, Inc. (EGIO) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Nutanix, Inc. (NTNX) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of G-III Apparel Group, Ltd. (GIII) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Horizon Bancorp, Inc. (HBNC) on Behalf of Investors Businesswire
16-Mar-2023 Level Ex Partners With Gladskin To Advance Education of Micreobalance® Skincare With Medical Video Games Businesswire
16-Mar-2023 Transgene: 2022 Full-year Results and Business Update Businesswire
16-Mar-2023 ISG Launches Training as a Service Capability Businesswire
16-Mar-2023 CORRECTING and REPLACING IPS Strengthens Biologics Expertise with New Team Members, Brian Horowski and Bob Forbes Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Horizon Bancorp, Inc. (HBNC) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of First Republic Bank (FRC) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors Businesswire
16-Mar-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amgen Inc. (AMGN) on Behalf of Investors Businesswire
16-Mar-2023 n-Lorem Foundation Begins 2023 with More Than 80 Active Patient Programs Businesswire
16-Mar-2023 Qosina Unveils New ISO 8 Cleanroom Businesswire
16-Mar-2023 Avania Names MedTech Industry Veteran, Todd M. Pope, New Chairman of the Board Businesswire
16-Mar-2023 Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris for the First and Only Orally Administered Approved Medicine for the Diagnosis of Growth Hormone Deficiency in Adults Businesswire
16-Mar-2023 Simulations Plus to Present at Sidoti March Small-Cap Conference Businesswire
16-Mar-2023 IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 Businesswire
16-Mar-2023 Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products Businesswire